Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The Herpesviridae Conserved Multifunctional Infected-Cell Protein 27 (ICP27) Is Important but Not Required for Replication and Oncogenicity of Marek's Disease Alphaherpesvirus.

Ponnuraj N, Tien YT, Vega-Rodriguez W, Krieter A, Jarosinski KW.

J Virol. 2019 Feb 5;93(4). pii: e01903-18. doi: 10.1128/JVI.01903-18. Print 2019 Feb 15.

PMID:
30518650
2.

Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 Expression.

Jarosinski KW, Carpenter JE, Buckingham EM, Jackson W, Knudtson K, Moffat JF, Kita H, Grose C.

Open Forum Infect Dis. 2018 May 22;5(6):ofy118. doi: 10.1093/ofid/ofy118. eCollection 2018 Jun.

3.

Interindividual Spread of Herpesviruses.

Jarosinski KW.

Adv Anat Embryol Cell Biol. 2017;223:195-224. doi: 10.1007/978-3-319-53168-7_9. Review.

PMID:
28528445
4.

Exocytosis of Varicella-Zoster Virus Virions Involves a Convergence of Endosomal and Autophagy Pathways.

Buckingham EM, Jarosinski KW, Jackson W, Carpenter JE, Grose C.

J Virol. 2016 Sep 12;90(19):8673-85. doi: 10.1128/JVI.00915-16. Print 2016 Oct 1.

5.
6.

Expression of fluorescent proteins within the repeat long region of the Marek's disease virus genome allows direct identification of infected cells while retaining full pathogenicity.

Jarosinski KW, Donovan KM, Du G.

Virus Res. 2015 Apr 2;201:50-60. doi: 10.1016/j.virusres.2015.02.012. Epub 2015 Feb 25.

PMID:
25725150
7.

A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.

Shaikh SA, Katneni UK, Dong H, Gaddamanugu S, Tavlarides-Hontz P, Jarosinski KW, Osterrieder N, Parcells MS.

Avian Dis. 2013 Jun;57(2 Suppl):509-18.

PMID:
23901769
8.

Marek's disease virus (MDV) ubiquitin-specific protease (USP) performs critical functions beyond its enzymatic activity during virus replication.

Veiga IB, Jarosinski KW, Kaufer BB, Osterrieder N.

Virology. 2013 Mar 15;437(2):110-7. doi: 10.1016/j.virol.2013.01.003. Epub 2013 Feb 9.

10.

Dual infection and superinfection inhibition of epithelial skin cells by two alphaherpesviruses co-occur in the natural host.

Jarosinski KW.

PLoS One. 2012;7(5):e37428. doi: 10.1371/journal.pone.0037428. Epub 2012 May 21.

11.

Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Jarosinski KW, Osterrieder N.

J Virol. 2012 Aug;86(15):7896-906. doi: 10.1128/JVI.00908-12. Epub 2012 May 16.

12.

Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivo.

Jarosinski KW, Arndt S, Kaufer BB, Osterrieder N.

J Virol. 2012 Mar;86(5):2428-36. doi: 10.1128/JVI.06719-11. Epub 2011 Dec 21.

13.

Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis.

Kaufer BB, Arndt S, Trapp S, Osterrieder N, Jarosinski KW.

PLoS Pathog. 2011 Oct;7(10):e1002333. doi: 10.1371/journal.ppat.1002333. Epub 2011 Oct 27.

14.

Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation.

Kaufer BB, Jarosinski KW, Osterrieder N.

J Exp Med. 2011 Mar 14;208(3):605-15. doi: 10.1084/jem.20101402. Epub 2011 Mar 7.

15.

Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Kaufer BB, Trapp S, Jarosinski KW, Osterrieder N.

PLoS Pathog. 2010 Aug 26;6(8):e1001073. doi: 10.1371/journal.ppat.1001073.

16.

Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion.

Jarosinski KW, Hunt HD, Osterrieder N.

Virology. 2010 Sep 30;405(2):457-63. doi: 10.1016/j.virol.2010.06.041. Epub 2010 Jul 15.

17.
18.

Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Chbab N, Egerer A, Veiga I, Jarosinski KW, Osterrieder N.

Vet Res. 2010 Sep-Oct;41(5):56. doi: 10.1051/vetres/2010026. Epub 2010 Apr 29.

19.

Selection for increased nitric oxide production does not increase resistance to Marek's disease in a primary broiler breeder line.

Buscaglia C, O'Connell PH, Jarosinski KW, Pevzner I, Schat KA.

Avian Dis. 2009 Sep;53(3):336-40.

PMID:
19848069
20.

Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, Brosnahan M, Buckles EL, Osterrieder N, Van de Walle GR.

PLoS One. 2009;4(1):e4118. doi: 10.1371/journal.pone.0004118. Epub 2009 Jan 5.

21.

Negative modulation of the chicken infectious anemia virus promoter by COUP-TF1 and an E box-like element at the transcription start site binding deltaEF1.

Miller MM, Jarosinski KW, Schat KA.

J Gen Virol. 2008 Dec;89(Pt 12):2998-3003. doi: 10.1099/vir.0.2008/003103-0.

PMID:
19008385
22.

Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Van de Walle GR, Jarosinski KW, Osterrieder N.

J Virol. 2008 Jul;82(13):6090-7. doi: 10.1128/JVI.00098-08. Epub 2008 Apr 2. Review. No abstract available.

23.

Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC.

Jarosinski KW, Margulis NG, Kamil JP, Spatz SJ, Nair VK, Osterrieder N.

J Virol. 2007 Oct;81(19):10575-87. Epub 2007 Jul 18.

24.

Marek's disease virus: lytic replication, oncogenesis and control.

Jarosinski KW, Tischer BK, Trapp S, Osterrieder N.

Expert Rev Vaccines. 2006 Dec;5(6):761-72. Review.

PMID:
17184215
25.

Isolation and molecular characterization of a new Muscovy duck parvovirus from Muscovy ducks in the USA.

Poonia B, Dunn PA, Lu H, Jarosinski KW, Schat KA.

Avian Pathol. 2006 Dec;35(6):435-41.

PMID:
17121731
26.
27.

Expression of Marek's disease virus phosphorylated polypeptide pp38 produces splice variants and enhances metabolic activity.

Li X, Jarosinski KW, Schat KA.

Vet Microbiol. 2006 Oct 31;117(2-4):154-68. Epub 2006 Jul 27.

PMID:
16876339
28.

Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a.

Jarosinski KW, Osterrieder N, Nair VK, Schat KA.

J Virol. 2005 Sep;79(18):11647-59.

29.

Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus.

Jarosinski KW, Njaa BL, O'connell PH, Schat KA.

Viral Immunol. 2005;18(1):148-61.

PMID:
15802959
30.

Positive and negative regulation of chicken anemia virus transcription.

Miller MM, Jarosinski KW, Schat KA.

J Virol. 2005 Mar;79(5):2859-68.

31.
32.

Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.

Jarosinski KW, O'Connell PH, Schat KA.

Virus Genes. 2003 May;26(3):255-69. Erratum in: Virus Genes. 2005 Mar;30(2):297.

PMID:
12876454
33.

Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection.

Jarosinski KW, Yunis R, O'Connell PH, Markowski-Grimsrud CJ, Schat KA.

Avian Dis. 2002 Jul-Sep;46(3):636-49.

PMID:
12243528
34.

Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes.

Jarosinski KW, Massa PT.

J Neuroimmunol. 2002 Jan;122(1-2):74-84.

PMID:
11777545
35.

Specific deficiency in nuclear factor-kappaB activation in neurons of the central nervous system.

Jarosinski KW, Whitney LW, Massa PT.

Lab Invest. 2001 Sep;81(9):1275-88.

PMID:
11555675
36.

Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha.

Jarosinski KW, Jia W, Sekellick MJ, Marcus PI, Schat KA.

J Interferon Cytokine Res. 2001 May;21(5):287-96.

PMID:
11429159
37.

Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes.

Massa PT, Saha S, Wu C, Jarosinski KW.

Glia. 2000 Feb 15;29(4):376-85.

PMID:
10652447
38.

Supplemental Content

Loading ...
Support Center